Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
18%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
PBPH
56
HOLDINGS
24%
ALSO IN IDNA
IDNA
52
HOLDINGS
32%
ALSO IN PBPH
SECTOR DRIFT (PBPH minus IDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBPH |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
| MERCK & CO. INC. | 5.7% | 3.5% | 3.5% | |
| VERTEX PHARMACEUTICALS INC | 2.8% | 3.3% | 2.8% | |
| GSK PLC | 2.0% | 2.7% | 2.0% | |
| SANOFI-AVENTIS | 1.9% | 2.7% | 1.9% | |
| REGENERON PHARMACEUTICALS | 1.6% | 3.4% | 1.6% | |
PBPH Overweight Relative to IDNA
| ELI LILLY & CO | 15.5% | |
| JOHNSON & JOHNSON | 10.0% | |
| ABBVIE INC | 7.2% | |
| ASTRAZENECA PLC | 4.7% | |
| AMGEN INC | 4.3% | |
| NOVARTIS AG | 4.2% | |
| GILEAD SCIENCES INC | 4.0% | |
| PFIZER INC | 3.5% | |
| BRISTOL-MYERS SQUIBB CO | 2.7% | |
| NOVO NORDISK A/S-B | 2.6% |
PBPH Underweight Relative to IDNA
| MODERNA, INC. | -12.3% | |
| TWIST BIOSCIENCE CORP. | -6.7% | |
| IOVANCE BIOTHERAPEUTICS INC | -5.2% | |
| GENMAB A/S | -4.0% | |
| IMMUNITYBIO INC | -3.6% | |
| BIONTECH SE SPONSORED ADR | -3.2% | |
| EXELIXIS INC | -3.0% | |
| REVOLUTION MEDICINES, INC. | -2.9% | |
| IDEAYA BIOSCIENCES, INC. | -2.7% | |
| ABCELLERA BIOLOGICS, INC. | -2.7% |